Results 101 to 110 of about 3,467,566 (283)

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

Double burden of under-5 mortality in LMICs

open access: yesThe Lancet Global Health, 2022
Macharia, Peter M, Beňová, Lenka
openaire   +2 more sources

Socio-economic and environmental differentials, and mortality in a developing urban area (Belo Horizonte - Brazil) [PDF]

open access: yes
Studies on health inequalities on developing cities are scarce. They have mainly focused on infant and child mortality and life expectancy at birth. Studies of adult mortality and cause- specific studies have seldom been
de Sousa, Romulo Paes
core   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

open access: yesMolecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou   +12 more
wiley   +1 more source

Explaining the Correlates of Child Mortality and Under-5 Survival in Nigeria

open access: yesMedical and Health Science Journal
Background: Survival of children under-5 is among the foremost public health concerns that has been pursued in the Sustainable Development Goals (SDGs). A proper understanding of the correlates of child survival is of paramount relevance to health policy formulation and development of interventions to promote child's health outcomes.
Molelekoa, Thonaeng Charity   +1 more
openaire   +4 more sources

Infant Mortality Task Force preliminary report

open access: yes, 2009
Title from PDF cover (viewed on May 26, 2010).; "June 2009."; Harvested from the web on 5/26 ...
Ohio. Infant Mortality Task Force.
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Quality of child health care and under-five-mortality in Zambia: [PDF]

open access: yes
This study was intended to investigate the factors associated with the high under-five mortality in one province of Zambia. Specifically the study (a) Identifies predominant traditional cultural beliefs and perceptions concerning main causes of child ...
Augustus Kapungwe
core  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy